Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Jianjun Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-2179-2388; OpenAlex author ID A5078400160; NIH RePORTER profile ID 8577608. Sources: OpenAlex.

Their work

Papers
17 (first author 0, last author 7)
Trials
0
Grants
2
Labs led
2
Collaborators
44
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: 1 grant · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: 3 papers · 2025: 4 papers, 1 grant

Papers 17

  1. Lead time trajectory of blood-based protein biomarkers for detection of pancreatic cancer based on repeat testing. Co-author DOI 10.1016/j.canlet.2025.217450↗
  2. Dietary intake of isoflavones and coumestrol and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial. Last author DOI 10.1038/s41416-024-02929-8↗
  3. Associations Between Intakes of Carotenoids and Tocopherols with Risk of Pancreatic Cancer in a Population-Based Case-Control Study. Last author DOI 10.1080/27697061.2024.2404578↗
  4. Integrated Metabolomics and Spatial Transcriptomics of Cystic Pancreatic Cancer Precursors Reveals Dysregulated Polyamine Metabolism as a Biomarker of Progress… Co-author DOI 10.1158/1078-0432.ccr-24-2931↗
  5. Associations between Two Dietary Quality Scores and Pancreatic Cancer Risk in a US National Prospective Cohort Study. Last author DOI 10.1080/27697061.2023.2289520↗
  6. Contributions of the Microbiome-Derived Metabolome for Risk Assessment and Prognostication of Pancreatic Cancer. Co-author DOI 10.1093/clinchem/hvad186↗
  7. A Blood-based Metabolite Signature for Personalized Risk Assessment of Pancreatic Cancer. Co-author DOI 10.33696/cancerimmunol.6.095↗
  8. Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an ea… Co-author DOI 10.1101/2023.08.14.553002↗
  9. Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Last author DOI 10.1002/oby.23550↗
  10. Intake of Calcium, Magnesium, and Phosphorus and Risk of Pancreatic Cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Last author DOI 10.1080/07315724.2021.1970047↗
  11. Associations between intake of calcium, magnesium and phosphorus and risk of pancreatic cancer: a population-based, case-control study in Minnesota. Last author DOI 10.1017/s0007114521000283↗
  12. Lead-Time Trajectory of CA19-9 as an Anchor Marker for Pancreatic Cancer Early Detection. Co-author DOI 10.1053/j.gastro.2020.11.052↗
  13. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer. Co-author DOI 10.1093/jnci/djy126↗
  14. Intake of methyl-related nutrients and risk of pancreatic cancer in a population-based case-control study in Minnesota. Last author DOI 10.1038/s41430-018-0228-5↗
  15. Cholecystectomy, gallstones, tonsillectomy, and pancreatic cancer risk: a population-based case-control study in Minnesota. Co-author DOI 10.1038/bjc.2014.154↗
  16. Genetic variability in energy balance and pancreatic cancer risk in a population-based case-control study in Minnesota. Co-author DOI 10.1097/mpa.0b013e3182a7c829↗
  17. Sequence variants in antioxidant defense and DNA repair genes, dietary antioxidants, and pancreatic cancer risk. Co-author PMID 21915362↗

Grants 2

  1. Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer U01CA239522↗
  2. Identifying insulin resistance biomarkers and metabolomic signature as predictors of precursors to pancreatic cancer R21CA209366↗

Closest collaborators

The 25 strongest of 44 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christian Max Schmidt · 6 shared papers, 2 shared grants, 2017–2025 · strength 2.26
  2. Johannes Francois Fahrmann · 7 shared papers, 2019–2025 · strength 1.13
  3. Anirban Maitra · 7 shared papers, 2019–2025 · strength 1.13
  4. Ehsan Irajizad · 6 shared papers, 2021–2025 · strength 1.06
  5. Margaret L. Hoyt · 5 shared papers, 2018–2024 · strength 0.93
  6. Michele Yip-Schneider · 6 shared papers, 2019–2025 · strength 0.91
  7. Jody V. Vykoukal · 6 shared papers, 2019–2025 · strength 0.91
  8. Samir Hanash · 6 shared papers, 2019–2025 · strength 0.91
  9. Hao Fan · 4 shared papers, 2018–2025 · strength 0.84
  10. Ricardo A. Léon-Letelier · 4 shared papers, 2023–2025 · strength 0.73
  11. Anna E. Prizment · 4 shared papers, 2014–2025 · strength 0.52
  12. Riccardo Ballarò · 2 shared papers, 2024–2025 · strength 0.41
  13. Kristin E. Anderson · 2 shared papers, 2021–2025 · strength 0.41
  14. Chunliang Liu · 1 shared paper, 2025 · strength 0.33
  15. Yihui Chen · 2 shared papers, 2023–2025 · strength 0.33
  16. Tianchen Sheng · 1 shared paper, 2025 · strength 0.27
  17. Christopher M. Schmidt · 1 shared paper, 2025 · strength 0.23
  18. Kristin E. Anderson · 3 shared papers, 2011–2014 · strength 0.15
  19. Fredrik I. Thege · 1 shared paper, 2023 · strength 0.13
  20. Jimin Min · 1 shared paper, 2023 · strength 0.13
  21. Robert A. Wolff · 1 shared paper, 2023 · strength 0.13
  22. Paola A. Guerrero · 1 shared paper, 2023 · strength 0.13
  23. Marta Sans · 1 shared paper, 2023 · strength 0.13
  24. Michael P. Kim · 1 shared paper, 2023 · strength 0.13
  25. Kristin E. Anderson · 1 shared paper, 2018 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.